Mahadali, Dinaven .
HRN: 25-25-90 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/09/2024
CEFTRIAXONE 1G (VIAL)
06/09/2024
06/15/2024
IV
2g
OD
UTI
Waiting Final Action